245 related articles for article (PubMed ID: 7671567)
1. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats.
Nakamura T; Kimura K; Ebihara I; Takahashi T; Tomino Y; Aikawa M; Yazaki Y; Nagai R; Koide H
Clin Sci (Lond); 1995 Jul; 89(1):45-52. PubMed ID: 7671567
[TBL] [Abstract][Full Text] [Related]
2. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
[TBL] [Abstract][Full Text] [Related]
3. Glomerular nonmuscle-type myosin heavy-chain isoform gene expression in glomerulosclerosis.
Ebihara I; Kimura K; Nakamura T; Tomino Y; Yazaki Y; Nagai R; Koide H
Nephron; 1998; 79(3):317-21. PubMed ID: 9678433
[TBL] [Abstract][Full Text] [Related]
4. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
Ebihara I; Nakamura T; Tomino Y; Koide H
Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
[TBL] [Abstract][Full Text] [Related]
5. Modulation of glomerular endothelin and endothelin receptor gene expression in aminonucleoside-induced nephrosis.
Nakamura T; Ebihara I; Fukui M; Osada S; Tomino Y; Masaki T; Goto K; Furuichi Y; Koide H
J Am Soc Nephrol; 1995 Feb; 5(8):1585-90. PubMed ID: 7756592
[TBL] [Abstract][Full Text] [Related]
6. Effects of enalapril treatment on gene expression of smooth muscle myosin heavy chain isoforms in glomeruli of diabetic rats.
Nakamura T; Ebihara I; Fukui M; Makita Y; Tomino Y; Kimura K; Nagai R; Yazaki Y; Koide H
Ren Physiol Biochem; 1995; 18(4):183-90. PubMed ID: 7481069
[TBL] [Abstract][Full Text] [Related]
7. Altered glomerular steady-state levels of tumour necrosis factor-alpha mRNA during nephrotic and sclerotic phases of puromycin aminonucleoside nephrosis in rats.
Nakamura T; Ebihara I; Fukui M; Takahashi T; Tomino Y; Koide H
Clin Sci (Lond); 1993 Mar; 84(3):349-56. PubMed ID: 8384958
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
Garin EH; Boggs KP; Burke FC
Int J Pediatr Nephrol; 1985; 6(2):117-20. PubMed ID: 4030221
[TBL] [Abstract][Full Text] [Related]
10. Modulation of basement membrane component gene expression in glomeruli of aminonucleoside nephrosis.
Nakamura T; Ebihara I; Shirato I; Tomino Y; Koide H
Lab Invest; 1991 May; 64(5):640-7. PubMed ID: 2030578
[TBL] [Abstract][Full Text] [Related]
11. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis.
Aikawa M; Sivam PN; Kuro-o M; Kimura K; Nakahara K; Takewaki S; Ueda M; Yamaguchi H; Yazaki Y; Periasamy M
Circ Res; 1993 Dec; 73(6):1000-12. PubMed ID: 7916668
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of CD54, CD18, MHC class II molecules, and proliferating cell nuclear antigen in acute puromycin aminonucleoside nephrosis.
Fernandez L; Romero M; Rincón J; Mosquera J
Nephron Exp Nephrol; 2003; 94(2):e55-65. PubMed ID: 12845231
[TBL] [Abstract][Full Text] [Related]
13. Key molecular events in puromycin aminonucleoside nephrosis rats.
Guan N; Ding J; Deng J; Zhang J; Yang J
Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
[TBL] [Abstract][Full Text] [Related]
14. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
Grond J; Weening JJ; Elema JD
Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of renal histamine in normal rat kidney and in nephrosis induced by aminonucleoside of puromycin.
Abboud HE; Ou SL; Velosa JA; Shah SV; Dousa TP
J Clin Invest; 1982 Feb; 69(2):327-36. PubMed ID: 7056851
[TBL] [Abstract][Full Text] [Related]
16. Nephrin and podocin expression around the onset of puromycin aminonucleoside nephrosis.
Hosoyamada M; Yan K; Nishibori Y; Takiue Y; Kudo A; Kawakami H; Shibasaki T; Endou H
J Pharmacol Sci; 2005 Feb; 97(2):234-41. PubMed ID: 15684566
[TBL] [Abstract][Full Text] [Related]
17. Effects of aminonucleoside, daunomycin, and adriamycin on carbon oxidation by glomeruli.
Kaplan BS; Renaud L; Drummond KN
Lab Invest; 1976 Feb; 34(2):174-8. PubMed ID: 1249918
[TBL] [Abstract][Full Text] [Related]
18. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat.
Holthöfer H; Reivinen J; Solin ML; Haltia A; Miettinen A
Am J Pathol; 1996 Sep; 149(3):1009-15. PubMed ID: 8780404
[TBL] [Abstract][Full Text] [Related]
19. Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis.
Ginevri F; Gusmano R; Oleggini R; Acerbo S; Bertelli R; Perfumo F; Cercignani G; Allegrini S; D'Allegri F; Ghiggeri G
Clin Sci (Lond); 1990 Mar; 78(3):283-93. PubMed ID: 2156648
[TBL] [Abstract][Full Text] [Related]
20. Effects of a low-protein diet on glomerular endothelin family gene expression in experimental focal glomerular sclerosis.
Nakamura T; Fukui M; Ebihara I; Osada S; Takahashi T; Tomino Y; Koide H
Clin Sci (Lond); 1995 Jan; 88(1):29-37. PubMed ID: 7704997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]